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Abstract: Antinociceptive and anti-inflammatory activities of the Muehlenbeckia platyclada 
leaves’ ethanol extract were investigated in animal models. The extract (p.o.) reduced the 
number  of  abdominal  contortions  induced  by  acetic  acid  by  21.57%  
(400 mg/kg). After intraplantar injection of formalin, a dose of 400 mg/kg (p.o.) inhibited 
the time spent paw licking in the first phase (26.43%), while the second phase was inhibited 
by 10.90 and 36.65% at the doses of 200 and 400 mg/kg, respectively. The extract (p.o.) 
increased the reaction time on a hot plate at a dose of 400 mg/kg (32.68 and 40.30%) after 
60 and 90 minutes of treatment, respectively. The paw edema was reduced by extract (p.o.) 
at  doses  of  100  (15.46  and  16.67%),  200  (22.68  and  25.64%)  and  400  mg/kg 
(29.50 and 37.33%) after 3 to 4 h of carrageenan application, respectively. Doses of 100, 
200 and 400 mg/kg (p.o.), administered 4 h after the carrageenan injection, reduced the 
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exudate  volume  (11.28,  21.54  and  45.13%),  while  leukocyte  migration  was  reduced  by 
21.21 and 29.70% at the doses of 200 and 400 mg/kg, respectively. These results indicate 
that  the  ethanol  extract  from  M.  platyclada  may  constitute  a  potential  target  for  the 
discovery of new molecules with antinociceptive and anti-inflammatory activities that can 
be explored for their therapeutic use.  
Keywords:  Muehlenbeckia  platyclada;  Polygonaceae;  antinociceptive  activity; 
anti-inflammatory activity 
 
1. Introduction 
Medicinal  plants  are  one  of  the  most  important  sources  of  active  substances  with  therapeutic 
potential  and  these  are  often  used  to  cure  a  variety  of  diseases  in  humans  [1,2].  Moreover,  the 
evaluation of pharmacological effects can be used as a strategy for discovering new drugs of plant 
origin [2,3]. In particular, the use of medicinal plants as anti-inflammatory and analgesic agents is a 
common practice and have been the target of recent studies [4,5].  
The genus  Muehlenbeckia  is  constituted by four species belonging to the family Polygonaceae. 
Plants  of  this  genus,  such  as  Muehlenbeckia  platyclada  (F.  Muell.)  Meisn.,  commonly  known  as 
carqueja de jardim or fita de moç a, are found in South America, and have been traditionally used as 
diuretic,  hypotensive, antihemorragic,  sedative, antirheumatic, abortive, cicatrizant,  antiulcerogenic, 
anti-inflammatory and anthelmintic agents [6,7]. 
Among  the  active  compounds  found  in  M.  platyclada,  the  flavonoids  (morin-3-O--
rhamnopyranoside,  kaempferol-3-O--rhamnopyranoside,  kaempferol-3-O--glucopyranoside, 
quercetin  3-O--rhamnopyranoside  and  (+)-catechin),  were  reported  [8].  However,  in  species  of 
Muehlenbeckia, such as M. tamnifolia, free anthraquinones (chrysophanic acid, emodin, and rhein) and 
glycoside anthraquinones have been identified [9]. Epicatechin, emodin-8-glycoside and rutin were 
identified  from  the  aerial  part  and  the  root  of  M.  hastulata  [10].  Pheophorbide  A,  hypericin  and 
protohypericin, isolated from this specie, demonstrated potent activity against influenza virus [11].  
Considering  pharmacological  studies,  M.  hastulata  possesses  significant  oxytoxic  and  analgesic 
activities  [10].  The  chloroform,  butanol  and  aqueous  extracts  as  well  as  flavonoids  isolated  from 
M. platyclada inhibited the generation of superoxide anion and elastase released by human neutrophils, 
indicating anti-inflammatory activity [8]. Based on the anthelmintic property, the methanolic extract of 
M. platyclada did not exhibit activity against Bursaphelenchus xylophilus [12]. 
In order to evaluate the pharmacological basis for a better understanding of the use of M. platyclada 
in  folk  medicine,  the  present  study  was  designed  to  investigate  the  antinociceptive  and  
anti-inflammatory effects of ethanol extract obtained from leaves using animal models. 
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2. Results and Discussion 
2.1. Phytochemistry Screening 
The phytochemical screening results of the ethanol extract showed the presence of different types of 
active constituents like flavonoids, terpenoids, sterols, coumarins, tannins, saponins and volatile oils. 
2.2. Acute Toxicity 
At the doses administered per oral route (p.o.), the ethanol extract from M. platyclada leaves was 
toxic to animals with LD50 of 2.67 g/kg (95% confidence intervals 1.65–4.31 g/kg). This result was 
applied  as  a  parameter  to  establish  the  dosage  definition  in  the  experiments  of  pharmacological 
activities. 
2.3. Writhing Response Induced by Acetic Acid in Mice 
Dose (p.o.) of 400 mg/kg of M. platyclada extract significantly reduced (p < 0.001) the abdominal 
contortions induced by acetic acid to 51.37  0.84 compared to the respective control (65.50  1.50) 
(Figure 1). 
Figure 1. Effects of the ethanol extract from M. platyclada leaves on acetic acid-induced 
writhing in mice. Data are mean  s.e.m. of eight mice. ***P < 0.001 vs. control group. 
 
2.4. Effects on Formalin-Induced Nociception in Mice 
The intraplantar injection of formalin promoted a biphasic characteristic response (Figure 2). The 
time spent licking in the first phase (0–5 min) was 84.62  2.45 s and in the second phase (15–30 min) 
was 91.75  1.79 s for the control group. After 60 min of treatment, a dose (p.o.) of 400 mg/kg of 
extract  significantly  inhibited  (p  <  0.001)  the  first  phase  at  26.43%  and  the  doses  of  200  and  
400 mg/kg reduced the second phase at 10.90 and 36.65%, respectively, when compared to the control. Int. J. Mol. Sci. 2010, 11                       
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Figure 2. Effects of the ethanol extract from M. platyclada leaves on formalin-induced 
nociception in mice. First phase = 0–5 min after formalin injection; second phase = 15–30 min. 
Data are mean  s.e.m. of eight mice. **P < 0.01; ***P < 0.001 vs. control group. 
 
2.5. Effects on Hot-Plate Latency Assay in Mice 
The  M.  platyclada  ethanol  extract  increased the latency time of mice exposed to  the hot  plate 
(Table 1). After 60 and 90 min of treatment, dose (p.o.) of 400 mg/kg (32.68 and 40.31%) increased 
significantly (p < 0.05 and p < 0.01, respectively) the latency time in the respective control group. 
Morphine proved to be a potent analgesic, increasing the latency time within the evaluation periods. 
Naloxone, an opioid antagonist, blocked the morphine action but did not alter the antinociceptive effect 
of the tested extracts. 
Table 1. Effects of the ethanol extract from M. platyclada leaves on the reaction time(s) of 
mice exposed to the hot-plate test. 
Group  Dose 
(mg/kg) 
Time after drug administration (seconds) 
0 min  30 min  60 min  90 min 
Control  Saline  5.25  0.65  5.75  0.59  6.12  0.64  6.50  0.57 
  100  5.12  0.48  6.00  0.73  6.37  0.46  6.62  0.62 
Ethanol Extract  200  5.37  0.73  6.12  0.74  6.50  0.63  6.75  0.59 
  400  5.12  0.83  6.37  0.73  8.12  0.40*  9.12  0.51** 
Morphine  1  5.50  0.57  9.50  0.82**  14.37  1.10***  17.37  0.86*** 
Naloxone + Morphine  1 + 1  5.37  0.70  7.50  0.68  7.50  0.38  6.87  0.48 
Naloxone + Extract  1 + 400  5.25  0.88  6.50  0.73  7.87  0,40*  8.50  0.53* 
Data are mean  s.e.m. of eight mice. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group. 
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2.6. Effects on Carrageenan-Induced Edema in Rats 
The M. platyclada ethanol extract anti-inflammatory effect evaluated by the paw edema method 
induced by carrageenan is shown in Table 2. Edema inhibition was observed 3 h after carrageenan 
application of doses (p.o.) of 100 (0.82  0.03; 1.46 %; p < 0.05), 200 (0.75  0.04; 22.70 %; p < 0.01) 
and 400 mg/kg (0.63  0.04; 35.05 %; p < 0.001). 4 h after carrageenan injections, the doses of 100 
(0.65  0.02; p < 0.05), 200 (0.58  0.03; p < 0.01) and 400 mg/kg (0.52  0.02; p < 0.001) reduced the 
respective paw edema (16.67, 25.64 and 33.33%). In this time, indomethacin also reduced the paw 
edema (39.74%). 
Table 2. Effects of the ethanol extract from M. platyclada leaves on carrageenan-induced 
paw edema in rats. 
Group  Dose 
(mg/kg) 
Volume of hind paw (mL) 
1 h  2 h  3 h  4 h 
Control  Saline  0.55  0.04  0.70  0.05  0.97  0.05  0.78  0.05 
  100  0.55  0.08  0.68  0.07  0.82  0.03*  0.65  0.02* 
Ethanol Extract  200  0.53  0.08  0.67  0.08  0.75  0.04**  0.58  0.03** 
  400  0.52  0.07  0.63  0.07  0.63  0.04***  0.52  0.02*** 
Indomethacin  10  0.50  0.09  0.60  0.08  0.62  0.05***  0.47  0.02*** 
Data are mean  s.e.m. of six rats. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group. 
2.7. Effects on Carrageenan-Induced Pleurisy in Rats 
The pleurisy effects demonstrated that doses (p.o.) of 100 (p < 0.05), 200 (p < 0.01) and 400 mg/kg 
(p < 0.001) of the extracts significantly reduced the exudate volume (Table 3). The number of total 
leukocytes was inhibited at the doses of 200 (p < 0.001) and 400 mg/kg (p < 0.001) (Table 3). The 
exudate volume was decreased by 11.28, 21.54 and 45.13% at doses (p.o.) of 100, 200 and 400 mg/kg 
compared to the respective control. Leukocyte migration inhibition also occurred from doses (p.o.) of 
200  (13.00    0.21  ×   10
3
 cells/mm
3;  p  <  0.001)  and  400  mg/kg  (11.60    0.32  ×   10
3
 cells/mm
3; 
p < 0.001). Indomethacin reduced the exudate volume and the leukocyte migration. 
Table 3. Effects of the ethanol extract from M. platyclada leaves on pleural exudation and 
number of leucocytes in carrageenan-induced pleurisy in rats.  
Group  Dose 
(mg/kg) 
Exudate volume 
(mL) 
Inhibition 
(%) 
Nº  Leucocytes  
(×  10
3 cells/mm
3) 
Inhibition 
(%) 
Control  Saline  1.95  0.08  -  16.50  0.50  - 
  100  1.73  0.03*  11.28  15.70  0.43  4.85 
Ethanol Extract  200  1.53  0.07**  21.54  13.00  0.21***  21.21 
  400  1.07  0.07***  45.13  11.60  0.32***  29.70 
Indomethacin  10  0.92  0.08***  52.82  10.10  0.35***  38.80 
Data are mean  s.e.m. of six rats. *P < 0.05; **P < 0.01, ***P < 0.001 vs. control group. 
The acute toxicity test showed that the M. platyclada leaves’ ethanol extract doses tested were toxic 
to mice. However, the largest dose administered (400 mg/kg) is less than the lowest dose applied for Int. J. Mol. Sci. 2010, 11                       
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determination of the LD50 (0.5 g/kg or 500 mg/kg). This is the first time that the toxic effect on plants 
of the genus Muehlenbeckia is described. Probably, the toxic effect of the ethanol extract is due to the 
presence of compounds, such as saponins [13,14]. In the present study, the LD50 was used to define the 
doses that were administered to the animals. 
Considering the antinociceptive activity, the intraperitoneal administration of acetic acid induces the 
synthesis of the prostaglandins and sympathomimetic system mediators like PGE2 and PGF2 [15]. 
Thus, the antinociceptive effect of the ethanol extract could be due to the inhibition of these mediators. 
This effect was also demonstrated by the biphasic response time of paw licking induced by formalin 
[16]. The first phase (0 to 5 min) corresponds to the neurogenic stage as an intensely painful process 
for  the  activation  of  nociceptive  pathways,  while  inflammation  mediators  are  produced  after  
15  minutes  of  formalin  application  (second  phase)  [16,17].  Substance  P  and  bradykinin  act  as 
mediators in the first phase, while histamine, serotonin, prostaglandin and bradykinin are involved in 
the nociceptive response of the second stage [17].  
The central action was confirmed in the hot plate test (400 mg/kg), showing that the maximum 
effect  was reached after 90 minutes. This test is considered to be sensitive to drugs acting at the 
supraspinal modulation level of the pain response [18], suggesting a possible modulatory effect of the 
extract. Furthermore, antinociceptive action was not dependent on the opioid system, because naloxone 
treatment did not reverse the produced effect [19,20].  
The algesia test induced by formalin also indicated a possible anti-inflammatory activity (the second 
phase  was  reduced  from  200  mg/kg).  This  activity  was  confirmed  by  the paw edema induced by 
carrageenan  in  rats,  an  animal  model  widely  used  to  investigate  anti-inflammatory  substances. 
Carrageenan induces paw edema resulting in the release of mediators such as histamine, serotonin, 
bradykinin, substance P, platelet activating factor and prostaglandins [21–27]. Oral treatment with the 
M.  platyclada  ethanol  extract  significantly  inhibited  the  paw  edema  from  100  mg/kg.  This  result 
suggests that the anti-inflammatory actions  of the extract  are related  to inhibition of one or more 
signaling intracellular pathways involved with the release of mediators mentioned above. 
The  formation  of  exudate  in  the  pleural  cavity  [28,29]  and  leukocyte  migration  [29,30]  were 
produced by intrapleural injection of carrageenan and this method was used to confirm the obtained 
paw  edema  results.  Non-steroidal  anti-inflammatory  drugs,  such  as  indomethacin,  inhibit  the 
accumulation  of  exudates  and  mobilization  of  leukocytes  between  3  and  6  h  after  application  of 
carrageenan [29,31]. The ethanol extract from M. platyclada reduced the volume of exudate and the 
leukocyte migration, also corroborating the anti-inflammatory activity (Tables 2 and 3). 
Our  phytochemical  screening  demonstrated  the  presence  of  flavonoids,  saponins,  tannins, 
terpenoids, sterols, coumarins, volatile oils, triterpenes and steroids. Flavonoids, like morin-3-O--
rhamnopyranoside,  kaempferol-3-O--rhamnopyranoside,  kaempferol-3-O--glucopyranoside, 
quercetin 3-O--rhamnopyranoside and (+)-catechin, have been isolated from M. platyclada [8]. These 
flavonoids inhibited the generation of superoxide anion and elastase released by human neutrophils, 
indicating anti-inflammatory activity [8]. Compounds like flavonoids [32] and triterpenes [33] have 
demonstrated  anti-inflammatory  activity,  which  may  explain  the  antinociceptive  activity  of  
M. platyclada.  
Several mechanisms of action could explain the pharmacological activities found in the present 
study.  Flavonoids,  for  example,  are  potent  inhibitors  of  nitric  oxide  synthase  type  2  and  protein Int. J. Mol. Sci. 2010, 11                       
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tyrosine kinases are important enzymes involved in the NO/cGMP pathway [34]. Flavonoids also can 
stimulate NOS-2 via indirect inhibition of the COX and/or lipoxygenase pathways [35] and of the 
protein kinase C and/or L-arginine/NO pathways [36]. These pathways have been implicated in a series 
of  molecular  events  related  to  the  nociceptive  [37]  and  inflammatory  [32]  processes.  In  addition, 
flavonoids have shown ability to block phospholipase A2 and phospholipase C, which are key enzymes 
in inflammation [38]. The ability of flavonoids and triterpenes to inhibit the nuclear factor-kappaB 
(NF-κB) could clarify the anti-inflammatory activity of the extract [39]. According to Suh et al. [40], 
the antinociceptive activity of saponin has been associated with the modulation of the GABAA, NMDA 
and  non-NMDA  receptors  at  the  supraspinal  level.  These  authors  have  also  reported  that  the 
nonopioid-mediated saponin antinociception is modulated via activation of the descending serotonin 
and  2-adrenergic  pathways.  However,  additional  studies  are  necessary  to  establish  the  possible 
correlation between activities and chemical composition of M. platyclada to ensure the appropriate 
medicinal use of this plant. 
3. Experimental Section 
3.1. Plant Material and Extraction 
The plant material used in this study was collected in Juiz de Fora, in the state of Minas Gerais, 
Brazil, in June 2008. The species was identified by Dr Fá tima Regina Gonç alves Salimena and a 
voucher specimen (CESJ number 53055) was deposited in the Herbarium of the Universidade Federal 
de Juiz de Fora, Brazil. Dried and powdered leaves (726 g) were exhaustively extracted in 95% ethanol 
(2.5  L)  by  static  maceration  for  three  weeks  at  room  temperature  with  renewal  of  solvent  every 
two days.  The  ethanol  extract  was  filtered  and  evaporated  under  a  rotary  evaporator  at  controlled 
temperature (50–60 ° C). This material was placed in a desiccator with silica to yield 42.72 g. The dried 
extract was dissolved using 1% DMSO in normal saline for pharmacological studies. 
3.2. Phytochemical Screening of the Ethanol Extract 
The screening of chemical constituents was carried out with the ethanol extracts using chemical 
methods  and thin-layer chromatography (TLC), according to the methodology suggested by Matos 
[41],  including  flavonoids,  tannins,  coumarins,  alkaloids,  saponins,  terpenoids,  steroids  and 
volatile oils.  
3.3. Chemicals 
Drugs  and  reagents  used  in  this  study  (and  their  sources)  were  as  follows:  acetic  acid  (Vetec 
Quí mica Farm Ltda, Rio de Janeiro, RJ, Brazil), formaldehyde (Reagen Quimibrá s Ind. Quí mica S.A., 
Rio  de  Janeiro,  RJ,  Brazil),  morphine  hydrochloride  (Merck  Inc.,  Whitehouse  Station,  NJ,  USA), 
naloxone and indomethacin (Sigma Chemical Co, St Louis, MI, U.S.). 
3.4. Animals 
Male Wistar rats (90–110 days) weighing 200–240 g and male Swiss albino mice (50–70 days) 
weighing 25–30 g were used in the experiments. The animals were provided by the Central Biotery of Int. J. Mol. Sci. 2010, 11                       
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the Universidade Federal de Juiz de Fora. The animals were divided into groups and kept in plastic 
cages (47 ×  34 ×  18 cm) under a 12 h light/12 h dark cycle at room temperature (22  2 º C), with free 
access to Purina rations and water. Animal care and the experimental protocol followed the principles 
and guidelines suggested by the Brazilian College of Animal Experimentation (COBEA) and were 
approved by the local ethical committee. 
3.5. Acute Toxicity 
Groups  of  ten  mice  received  oral  doses  of  0.5,  1,  1.5,  2  and  3  g/kg  of  ethanol  extract  from 
M. platyclada, while the control group received the vehicle (saline). The groups were observed for 48 h 
and mortality at end of this period was recorded for each group [42]. The LD50 (50% lethal dose) was 
determined by probit test using a log plot of percentage death versus dose [43]. The determination of 
LD50 served to define the doses used in experiments of pharmacological activities. 
3.6. Acetic Acid-Induced Writhing Response in Mice 
Antinociceptive activity was evaluated using the test of abdominal writhing induced by acetic acid 
in mice [44]. Animals were divided into groups of eight mice. Control mice received an i.p. injection 
of acetic acid 0.6% (0.25 mL) and 10 min later the writhes were counted over a period of 20 min. One 
group of mice received indomethacin (10 mg/kg) by the per oral route (p.o.) as a reference compound, 
and the other three groups received the extract at doses (p.o.) of 100, 200 and 400 mg/kg, 1 h before 
the acetic acid injection. 
3.7. Formalin-Induced Nociception in Mice 
Mice received subplantar injections of 20 L 2.5% formalin (in 0.9% saline) and the time of paw 
licking (in seconds) was determined over 0–5 min (first phase - neurogenic) and 15–30 min (second 
phase - inflammatory) after formalin injection [16]. Animals (n = 8) were pretreated p.o. with extract 
(100, 200 or 400 mg/kg; 0.1 mL per 10 g body weight) or the reference compound, subcutaneous 
morphine (1 mg/kg), 1 h before administration of formalin. Control animals were treated with sterile 
saline (10 mL/kg). 
3.8. Hot-Plate Latency Assay in Mice 
Animals  were placed on a hot-plate (Model LE 7406, Letica Scientific Instruments, Barcelona, 
Spain) heated at 55  1 ° C [45]. Three groups of mice (n = 8) were treated p.o. with ethanol extract 
(100, 200 or 400 mg/kg; 0.1 mL per 10 g body weight); the control group received sterile saline 
(10 mL/kg). Measurements were performed at time 0, 30, 60 and 90 min after drug administration, 
with a cut-off time of 40 s to avoid lesions to the animals’ paws. The effect of pretreatment with 
naloxone (1 mg/kg, subcutaneously) on the analgesia produced by the ethanol extract (400 mg/kg) was 
determined in a separate group of animals. Morphine (1 mg/kg, subcutaneously), in the absence and 
presence of naloxone treatment, was used as a reference. 
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3.9. Carrageenan-Induced Edema in Rats 
Anti-inflammatory activity was assessed on the basis of inhibition of paw edema induced by the 
injection of 0.1 mL of 2% carrageenan (an edematogenic agent) into the subplantar region of the right 
hind paw of the rat [46]. Male Wistar rats were divided into groups of six animals which received p.o. 
doses of extract (100, 200 and 400 mg/kg; 0.1 mL per 10 g body weight), saline or indomethacin 
(10 mg/kg) 1 h before the injection of carrageenan. In the left paw, used as a control, 0.1 mL of sterile 
saline was injected. 1, 2, 3 and 4 h after injection of carrageenan, the measure of edema was made by 
the difference between the volume displaced by the right paw and the left paw using a plethysmometer 
(model LE 7500, Letica Scientific Instruments, Barcelona, Spain). 
3.10. Carrageenan-Induced Pleurisy in Rats 
Pleurisy was induced in male Wistar rats by intrapleural administration of 0.5 mL 2% carrageenan 
suspension in saline solution between the third and fifth ribs on the right side of the mediastinum [37]. 
Extract (100, 200 and 400 mg/kg), saline or indomethacin (10 mg/kg) p.o. were given 60 min before 
injection of the irritant. Animals were killed 4 h after carrageenan injection, and the skin and pectoral 
muscles were retracted. A longitudinal incision was made between the third and fifth ribs on each side 
of the mediastinum. The exudate was collected and transferred to a 15 mL conical centrifuge tube and 
the total volume determined. A 20 L aliquot of the exudate was used to determine the total leucocyte 
count in Neubauer chambers. 
3.11. Calculus and Statistical Analysis 
Data are expressed as mean  s.e.m. Statistical significance was determined by one-way analysis of 
variance  followed  by  the  Student–Newman–Keuls  test.  P  values  below  0.05  were  considered 
significant. The percentage of inhibition was calculated by using 
100 − T ×  100/C(%) or T ×  100/C − 100(%) 
where C and T indicate non-treated (vehicle) and drug-treated, respectively. 
4. Conclusions 
The  present  study  demonstrated  that  the  ethanol  extract  from  M.  platyclada  leaves  possesses 
antinociceptive and anti-inflammatory activities that could be related to the synergistic activity of the 
bioactive compounds, particularly flavonoids, triterpenes, saponins, and steroids. The results support 
the  folklore  use  of  this  plant,  but  phytochemical  studies  together  with  pharmacological  and 
toxicological investigations are essential for complete understanding of the medicinal application. 
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